Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β via exchangle
Weight gain related to treatment with atypical antipsychotics is due to activation of PKC-β via exchangle
Atypical antipsychotics (APDs) are currently used in clinical practice for a variety of mental disorders such as schizophrenia, bipolar disorder and severe behavioral disturbances. A well-known disadvantage of using these compounds is a propensity for weight gain, resulting frequently in obesity. Th
Source:
www.exchangle.com
You've added this content to your favorites.
Post your comment
Load More
